InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Edwards Jeffrey l, 董事. Officer active across 4 companies, notably FIBROGEN INC. In total, 11 reports have been published. History available since 26 May 2021. The latest transaction was filed on 21 April 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Edwards Jeffrey l
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
407 股0Bio-Rad A Common StockSEC:0001190642-26-000002:0
308 股0Bio-Rad A Common StockSEC:0001062993-25-007905:0
30,000 股Common StockSEC:0001628280-24-031630:0
9,554 股Common StockSEC:0001628280-24-003134:0
8,289 股0Common StockSEC:0001209191-23-036076:0
18,182 股Common StockSEC:0001628280-23-020831:0
9,474 股Common StockSEC:0001628280-23-020580:0
15,777 股0Common StockSEC:0001209191-22-038609:0
7,059 股@ US$9.5040.7% 占其流量Common StockSEC:0001628280-22-016486:0
5,398 股@ US$9.7742.2% 占其流量Common StockSEC:0001593968-21-002278:0
4,700 股0Common StockSEC:0001209191-21-036675:0
11 条申报中的 11 条
About Edwards Jeffrey l
EDWARDS JEFFREY L is Director at LIFECORE BIOMEDICAL, INC. \DE\, FIBROGEN INC, Bio-Rad Laboratories, INC., and Landec CORP \ca\. He has 11 filings in total, and the most recent filings we hold cover the period from 2021-05-28 to 2026-04-23. In that recent sample, the buy and sell amounts are EUR 0 and EUR 0, and the modal transaction nature is Attribution.
